• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终产物修饰的β2-微球蛋白调节人成纤维细胞的胶原蛋白合成。

Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.

作者信息

Owen W F, Hou F F, Stuart R O, Kay J, Boyce J, Chertow G M, Schmidt A M

机构信息

Department of Medicine, Brigham & Women's Hospital Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Kidney Int. 1998 May;53(5):1365-73. doi: 10.1046/j.1523-1755.1998.00882.x.

DOI:10.1046/j.1523-1755.1998.00882.x
PMID:9573554
Abstract

Beta 2-microglobulin amyloidosis (A beta 2m) is a serious complication for patients undergoing long-term dialysis. beta 2-microglobulin modified with advanced glycation end products (beta 2m-AGE) is a major component of the amyloid in A beta 2m. It is not completely understood whether beta 2m-AGE plays an active role in the pathogenesis of A beta 2m, or if its presence is a secondary event of the disease. beta 2-microglobulin amyloid is mainly located in tendon and osteo-articular structures that are rich in collagen, and local fibroblasts constitute the principal cell population in the synthesis and metabolism of collagen. Recent identification of AGE binding proteins on human fibroblasts lead to the hypothesis that the fibroblast may be a target for the biological action of beta 2m-AGE. The present study demonstrated that two human fibroblast cell lines exhibited a decrease in procollagen type I mRNA and type I collagen synthesis after exposure to beta 2m-AGE for 72 hours. Similar results were observed using AGE-modified albumin. Antibody against the RAGE, the receptor for AGE, attenuated this decrease in synthesis, indicating that the response was partially mediated by RAGE. In addition, antibody against epidermal growth factor (EGF) attenuated the decrease in type I procollagen mRNA and type I collagen induced by beta 2m-AGE, suggesting that EGF acts as an intermediate factor. These findings support the hypothesis that beta 2m-AGE actively participates in connective tissue and bone remodeling via a pathway involving fibroblast RAGE, and at least one interposed mediator, the growth factor EGF.

摘要

β2-微球蛋白淀粉样变性(Aβ2m)是长期透析患者的一种严重并发症。经晚期糖基化终产物修饰的β2-微球蛋白(β2m-AGE)是Aβ2m淀粉样蛋白的主要成分。β2m-AGE在Aβ2m发病机制中是否发挥积极作用,或者其存在是否是该疾病的继发事件,目前尚未完全明确。β2-微球蛋白淀粉样蛋白主要位于富含胶原蛋白的肌腱和骨关节结构中,局部成纤维细胞是胶原蛋白合成和代谢的主要细胞群体。最近在人成纤维细胞上鉴定出AGE结合蛋白,由此提出成纤维细胞可能是β2m-AGE生物学作用靶点的假说。本研究表明,两种人成纤维细胞系在暴露于β2m-AGE 72小时后,I型前胶原mRNA和I型胶原合成减少。使用AGE修饰的白蛋白也观察到了类似结果。抗AGE受体RAGE的抗体减弱了这种合成减少,表明该反应部分由RAGE介导。此外,抗表皮生长因子(EGF)抗体减弱了β2m-AGE诱导的I型前胶原mRNA和I型胶原的减少,提示EGF作为中间因子发挥作用。这些发现支持了β2m-AGE通过涉及成纤维细胞RAGE和至少一种中间介质生长因子EGF的途径积极参与结缔组织和骨重塑的假说。

相似文献

1
Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.晚期糖基化终产物修饰的β2-微球蛋白调节人成纤维细胞的胶原蛋白合成。
Kidney Int. 1998 May;53(5):1365-73. doi: 10.1046/j.1523-1755.1998.00882.x.
2
Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.晚期糖基化终产物修饰的β2-微球蛋白参与血液透析相关淀粉样变的发病机制。诱导人单核细胞趋化以及巨噬细胞分泌肿瘤坏死因子-α和白细胞介素-1。
J Clin Invest. 1994 Feb;93(2):521-8. doi: 10.1172/JCI117002.
3
Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.β2-微球蛋白与晚期糖基化终产物在透析相关性淀粉样变发展过程中的相互作用。
Kidney Int. 1997 May;51(5):1514-9. doi: 10.1038/ki.1997.208.
4
beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.经晚期糖基化终末产物修饰的β2-微球蛋白是血液透析相关淀粉样变的主要成分。
J Clin Invest. 1993 Sep;92(3):1243-52. doi: 10.1172/JCI116696.
5
Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.晚期糖基化终产物修饰的β2-微球蛋白诱导人巨噬细胞产生白细胞介素-6:在血液透析相关淀粉样变发病机制中的作用
Biochem Biophys Res Commun. 1994 Jun 30;201(3):1235-41. doi: 10.1006/bbrc.1994.1837.
6
beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.晚期糖基化终产物修饰的β2微球蛋白可延迟单核细胞凋亡。
Kidney Int. 2001 Mar;59(3):990-1002. doi: 10.1046/j.1523-1755.2001.059003990.x.
7
The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.晚期糖基化终末产物受体(RAGE)是通过氧化敏感途径介导AGE-β2微球蛋白与人单核吞噬细胞相互作用的核心介质。对透析相关淀粉样变发病机制的启示。
J Clin Invest. 1996 Sep 1;98(5):1088-94. doi: 10.1172/JCI118889.
8
New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.透析相关性淀粉样变发病机制的新进展:肾衰竭中晚期糖基化终产物的病理生理学
Nihon Jinzo Gakkai Shi. 1996 May;38(5):191-7.
9
The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.晚期糖基化终末产物受体在皮肤中高度表达,并被晚期糖基化终末产物和肿瘤坏死因子-α上调。
J Invest Dermatol. 2006 Feb;126(2):291-9. doi: 10.1038/sj.jid.5700070.
10
Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis.人滑膜成纤维细胞上晚期糖基化终末产物受体:在透析相关淀粉样变发病机制中的作用
J Am Soc Nephrol. 2002 May;13(5):1296-1306. doi: 10.1681/ASN.V1351296.

引用本文的文献

1
Distinct Ocular Surface Microbiome in Keratoconus Patients Correlate With Local Immune Dysregulation.圆锥角膜患者独特的眼表微生物群与局部免疫失调相关。
Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):60. doi: 10.1167/iovs.66.1.60.
2
Protective Effect of Djulis () Extract against UV- and AGEs-Induced Skin Aging via Alleviating Oxidative Stress and Collagen Degradation.独活提取物通过减轻氧化应激和胶原降解对 UV 和 AGEs 诱导的皮肤衰老的保护作用。
Molecules. 2022 Apr 4;27(7):2332. doi: 10.3390/molecules27072332.
3
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature.
晚期糖基化终末产物(AGEs)、AGEs受体、糖尿病与骨骼:文献综述
J Endocr Soc. 2019 Jul 10;3(10):1799-1818. doi: 10.1210/js.2019-00160. eCollection 2019 Oct 1.
4
Advanced Glycation End-Products Suppress Mitochondrial Function and Proliferative Capacity of Achilles Tendon-Derived Fibroblasts.晚期糖基化终产物抑制跟腱衍生成纤维细胞的线粒体功能和增殖能力。
Sci Rep. 2019 Aug 30;9(1):12614. doi: 10.1038/s41598-019-49062-8.
5
AGE-RAGE signal generates a specific NF-κB RelA "barcode" that directs collagen I expression.衰老相关的晚期糖基化终末产物受体(AGE-RAGE)信号产生一种特定的核因子κB(NF-κB)RelA“条形码”,该条形码指导I型胶原蛋白的表达。
Sci Rep. 2016 Jan 5;6:18822. doi: 10.1038/srep18822.
6
Biological Effects Induced by Specific Advanced Glycation End Products in the Reconstructed Skin Model of Aging.特定晚期糖基化终产物在衰老皮肤重建模型中诱导的生物学效应
Biores Open Access. 2015 Jan 1;4(1):54-64. doi: 10.1089/biores.2014.0053. eCollection 2015.
7
RAGE, receptor of advanced glycation endoproducts, negatively regulates chondrocytes differentiation.晚期糖基化终末产物受体(RAGE)对软骨细胞分化起负向调节作用。
PLoS One. 2014 Oct 2;9(9):e108819. doi: 10.1371/journal.pone.0108819. eCollection 2014.
8
Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke.血管紧张素受体阻滞剂(ARB)替米沙坦、厄贝沙坦和坎地沙坦在预防和急性治疗中风中抑制 HMGB1/RAGE 轴的潜力。
Int J Mol Sci. 2013 Sep 13;14(9):18899-924. doi: 10.3390/ijms140918899.
9
Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes.退伍军人的关节成形术:对软骨、骨骼、血清和滑液的分析揭示了伴和不伴糖尿病共病的骨关节炎的差异与相似之处。
J Rehabil Res Dev. 2011;48(10):1195-210. doi: 10.1682/jrrd.2010.09.0186.
10
Natural history of age-related retinal lesions that precede AMD in mice fed high or low glycemic index diets.高或低升糖指数饮食喂养的小鼠中与年龄相关的 AMD 前视网膜病变的自然史。
Invest Ophthalmol Vis Sci. 2012 Feb 2;53(2):622-32. doi: 10.1167/iovs.11-8545.